Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × camrelizumab × Clear all

NCT02721589 2023-02-28

A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors